Background Contrast-enhanced mammography (CEM) is a promising technique for breast
cancer detection, but conflicting results have been reported in previous meta-analyses …

Screening for breast cancer reduces breast cancer–related mortality and earlier detection
facilitates less aggressive treatment. Unfortunately, current screening modalities are …

Background Reducing the amount of contrast agent needed for contrast-enhanced breast
MRI is desirable. Purpose To investigate if generative adversarial networks (GANs) can …

Background Integrated PET/MRI is a promising modality for breast assessment. The most
frequently used tracer, fluorine 18 (18F) fluorodeoxyglucose (FDG), is applied for whole …

Breast magnetic resonance imaging (MRI) is the most sensitive imaging modality for breast
cancer diagnosis and is widely used clinically. Dynamic contrast-enhanced MRI is the basis …

Background There is an increasing need to develop a more accurate prediction model for
pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast …

Imaging is paramount for the early detection and clinical staging of breast cancer, as well as
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …

Background Supplemental screening with MRI has proved beneficial in women with
extremely dense breasts. Most MRI examinations show normal anatomic and physiologic …

Background: To provide a systematic review and meta-analysis that evaluates the diagnostic
accuracy of contrast-enhanced mammography (CEM) compared to standard contrast …

Purpose: Diffusion-weighted imaging with the calculation of an apparent diffusion coefficient
(ADC) has been proposed as a quantitative biomarker on contrast-enhanced MRI (CE-MRI) …